Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy (OPTILIV)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2013 by Association pour la Recherche sur le Temps Biologique et la Chronothérapie.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Gustave Roussy, Cancer Campus, Grand Paris
Merck Serono International SA
Pfizer
CRESGE
Information provided by (Responsible Party):
Association pour la Recherche sur le Temps Biologique et la Chronothérapie
ClinicalTrials.gov Identifier:
NCT00852228
First received: February 25, 2009
Last updated: December 10, 2013
Last verified: December 2013